Status:
UNKNOWN
Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Chronic Pain
Opiate Withdrawal Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This project aims at examining the following hypotheses: * Treatment with NADA and clonidine reduces intensity of withdrawal symptoms to a greater extent than treatment with clonidine. * Opioid withd...
Eligibility Criteria
Inclusion
- Chronic pain patients treated with opioids over 3 months
- The patient's doctor or nurse assesses that there is an indication to opioid withdrawal and / or the patient wishes to withdraw.
- The patient is motivated for opioid withdrawal
- The patient has experienced withdrawal symptoms
- The patient must be able to understand, speak and write Danish
- The patient must be able to transport himself to the pain center
Exclusion
- Children under 18 years old
- External ear infection
- Treatment with benzodiazepines.
- Active substance abuse and alcohol abuse.
- Contraindications for treatment with clonidine:
- Allergy
- Bradyarrhythmias caused by diseased sinus cube or AV block of 2nd or 3rd grade.
- lactose intolerance
- Heart failure
- High medullary damage
- Cardiac conduction disturbances
- Pregnancy and breastfeeding
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03397212
Start Date
January 15 2018
End Date
January 15 2024
Last Update
January 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100